The Endocrine Society hosts a 2nd forum on EDCs and releases a scientific statement:
Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009 Jun;30(4):293-342.
EU Plant Protection Product Regulation (EC) No 1107/2009 and Commission Regulation (EU) 2018/605: Approval criteria for basic substances: “does not have an inherent capacity to cause endocrine disrupting, neurotoxic or immunotoxic effects.”
Cosmetics Products Regulation (EC) No 1223/2009, “When Community or internationally agreed criteria for identifying substances with endocrine-disrupting properties are available, or at the latest on 11 January 2015, the Commission shall review this Regulation with regard to substances with endocrine-disrupting properties.”
BPA review: Dr. Laura Vandenberg and other experts discuss the controversies surrounding EDCs:
Vandenberg, L. N., Maffini, M. V., Sonnenschein, C., Rubin, B. S., & Soto, A. M. (2009). Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocrine reviews, 30(1), 75–95.